Global ultra low temperature freezer market growth is driven by increasing demand for these freezers from biobanks and biopharmaceutical companies. Ultra low temperature freezers are medical grade storage systems that are capable of maintaining temperatures below -80 degree Celsius, thus, making them highly suitable for storing temperature sensitive materials like vaccines, blood, tissue samples and other biological specimens. These prevent degradation of samples at sub-zero temperatures over long periods. Growing investments in life science research and rising focus on developing new therapeutics has boosted the need for reliable sample storage, thus, driving the ultra low temperature freezer market growth. Increasing prevalence of chronic diseases has prompted drug manufacturers and research institutes to scale up their R&D activities, thus, boosting demand for such specialized freezer systems.
Market Dynamics:
Global ultra low temperature freezer market growth is driven by growing biobanking industry and rising pharmaceutical R&D spending in the near future. The need for safely preserving biological samples and cell cultures over long run can drive the market growth. Moreover, technological advancements facilitating remote temperature monitoring and improved sample security solutions boosts adoption. However, high costs of these systems as compared to conventional freezers can hamper the market growth. Concerns over operational failures posing risk of sample loss pose a challenge. Development of energy-efficient and sustainable freezer models can offer opportunities for the market growth. Growing investments by governments worldwide in life science infrastructure can drive the market growth during the forecast period.
Key Features of the Study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook